Gastric cancer patients less than 50 years of age exhibit significant downregulation of E-cadherin and CDX2 compared to older reference populations

American Cancer Society, 2011 Brenner, 2009, Epidemiology of stomach cancer, Methods Mol Biol, 472, 467, 10.1007/978-1-60327-492-0_23 Isobe, 2011, Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry, Gastric Cancer, 14, 301, 10.1007/s10120-011-0085-6 Kath, 2000, Gastric cancer in very young adults: apropos four patients and a review of the literature, J Cancer Res Clin Oncol, 126, 233, 10.1007/s004320050038 Koea, 2000, Gastric cancer in young patients: demographic, clinicopathological, and prognostic factors in 92 patients, Ann Surg Oncol, 7, 346, 10.1007/s10434-000-0346-9 Choi, 1996, Gastric cancer in young patients who underwent curative resection. Comparative study with older patients, Am J Clin Oncol, 19, 45, 10.1097/00000421-199602000-00010 Schildberg, 2012, Differences in the treatment of young gastric cancer patients: patients under 50 years have better 5-year survival than older patients, Adv Med Sci, 57, 259, 10.2478/v10039-012-0052-4 Yang, 2011, Survival of metastatic gastric cancer: significance of age, sex and race/ethnicity, J Gastrointest Oncol, 2, 77 Maehara, 1996, Age-related characteristics of gastric carcinoma in young and elderly patients, Cancer, 77, 1774, 10.1002/(SICI)1097-0142(19960501)77:9<1774::AID-CNCR3>3.0.CO;2-C Yokota, 1999, Early gastric cancer in the young: clinicopathological study, Aust N Z J Surg, 69, 443, 10.1046/j.1440-1622.1999.01553.x Kim, 2005, Clinicopathologic characteristics of gastric carcinoma in elderly patients: a comparison with young patients, World J Gastroenterol, 11, 22, 10.3748/wjg.v11.i1.22 Jang, 2011, Molecular pathology of gastric carcinoma, Pathobiology, 78, 302, 10.1159/000321703 Bai, 2013, PTEN expression and suppression of proliferation are associated with CDX2 overexpression in gastric cancer cells, Int J Oncol, 42, 1682, 10.3892/ijo.2013.1875 Gurel, 1999, Expression of p53 protein and prognosis in gastric carcinoma, J Int Med Res, 27, 85, 10.1177/030006059902700205 Kim, 2008, Metastasis-associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancer, Cancer Invest, 26, 152, 10.1080/07357900701518909 Okayama, 2009, CD44v6, MMP-7 and nuclear CDX2 are significant biomarkers for prediction of lymph node metastasis in primary gastric cancer, Oncol Rep, 22, 745 Warneke, 2013, Prognostic and putative predictive biomarkers of gastric cancer for personalized medicine, Diagn Mol Pathol, 22, 127, 10.1097/PDM.0b013e318284188e Zhou, 2002, Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival, World J Gastroenterol, 8, 987, 10.3748/wjg.v8.i6.987 Levine, 1997, p53, the cellular gatekeeper for growth and division, Cell, 88, 323, 10.1016/S0092-8674(00)81871-1 Dameron, 1994, The p53 tumor suppressor gene inhibits angiogenesis by stimulating the production of thrombospondin, Cold Spring Harb Symp Quant Biol, 59, 483, 10.1101/SQB.1994.059.01.053 Yamada, 1991, p53 gene mutations in gastric cancer metastases and in gastric cancer cell lines derived from metastases, Cancer Res, 51, 5800 Hayes, 2013, Downregulation of CDX2 in gastrointestinal neoplasia, J Clin Pathol, 66, 825, 10.1136/jclinpath-2013-201696 Park, 2010, CDX2 expression in the intestinal-type gastric epithelial neoplasia: frequency and significance, Mod Pathol, 23, 54, 10.1038/modpathol.2009.135 Xie, 2010, Overexpression of CDX2 inhibits progression of gastric cancer in vitro, Int J Oncol, 36, 509 Ge, 2008, A clinicopathological study on the expression of cadherin-17 and caudal-related homeobox transcription factor (CDX2) in human gastric carcinoma, Clin Oncol (R Coll Radiol), 20, 275, 10.1016/j.clon.2008.01.013 Ru, 2012, Detection and clinical significance of lymph node micrometastasis in gastric cardia adenocarcinoma, J Int Med Res, 40, 293, 10.1177/147323001204000129 Qin, 2012, Expression and significance of homeodomain protein CDX2 in gastric carcinoma and precancerous lesions, World J Gastroenterol, 18, 3296 Yagi, 2000, Cadherin superfamily genes: functions, genomic organization, and neurologic diversity, Genes Dev, 14, 1169, 10.1101/gad.14.10.1169 Lazar, 2010, The immunohistochemical expression of the p53-protein in gastric carcinomas. Correlation with clinicopathological factors and survival of patients, Rom J Morphol Embryol, 51, 249 Sheen-Chen, 2007, Signal transducer and activator of transcription 1 in breast cancer: analysis with tissue microarray, Anticancer Res, 27, 2481 Graziano, 2004, Prognostic analysis of E-cadherin gene promoter hypermethylation in patients with surgically resected, node-positive, diffuse gastric cancer, Clin Cancer Res, 10, 2784, 10.1158/1078-0432.CCR-03-0320 Ohno, 2006, Prognostic significance of combined expression of MUC1 and adhesion molecules in advanced gastric cancer, Eur J Cancer, 42, 256, 10.1016/j.ejca.2005.10.017 Xing, 2013, The prognostic value of E-cadherin in gastric cancer: a meta-analysis, Int J Cancer, 132, 2589, 10.1002/ijc.27947 Li, 2012, Abnormal expression of E-cadherin in tumor cells is associated with poor prognosis of gastric carcinoma, J Surg Oncol, 106, 304, 10.1002/jso.23008 Goncalves, 2011, Prognostic significance of p53 protein expression in early gastric cancer, Pathol Oncol Res, 17, 349, 10.1007/s12253-010-9333-z Sumiyoshi, 2006, Overexpression of hypoxia-inducible factor 1alpha and p53 is a marker for an unfavorable prognosis in gastric cancer, Clin Cancer Res, 12, 5112, 10.1158/1078-0432.CCR-05-2382 Monig, 1997, p53 expression in gastric cancer: clinicopathological correlation and prognostic significance, Dig Dis Sci, 42, 2463, 10.1023/A:1018844008068 Wang, 2012, Prognostic significance of CDX2 immunohistochemical expression in gastric cancer: a meta-analysis of published literatures, J Exp Clin Cancer Res, 31, 98, 10.1186/1756-9966-31-98